Table 2.
List of healthy donors that participated in this study
| Laboratory code | Sex | Age | PCR array cohort | RT-qPCR cohort | WB cohort | IF cohort | IP cohort |
|---|---|---|---|---|---|---|---|
| DOD 2 | Female | 25 | X | X | |||
| DOD 3 | Female | 32 | X | X | |||
| DOD 5 | Male | 23 | X | X | X | ||
| DOD 08/16 | Male | 32 | X | X | |||
| DOD 09/16 | Male | 25 | X | X | |||
| DOD 10/16 | Male | 18 | X | X | |||
| DOD 3/17 | Female | 30 | X | X | X | X | |
| DOD 4/17 | Male | 28 | X | X | X | X | |
| DOD 5/17 | Male | 45 | X | X | X | ||
| DOD 6/17 | Female | 22 | X | ||||
| DOD 48 | Female | 32 | X | ||||
| DOD 50 | Male | 29 | X | ||||
| DOD 55 | Female | 55 | X | ||||
| DOD 60 | Male | 61 | X | ||||
| DOD 61 | Male | 32 | X | ||||
| DOD 96 | Male | 25 | X | X | |||
| DOD 97 | Male | 18 | X | ||||
| DOD 100 | Male | 19 | X | X | X | ||
| DOD 101 | Female | 24 | X | X | X | ||
| DOD 102 | Female | 60 | X | X | |||
| DOD 103 | Male | 26 | X | ||||
| DOD 104 | Female | 33 | X | X | |||
| DOD 106 | Female | 19 | X | ||||
| DOD 107 | Male | 25 | X | ||||
| DOD 108 | Female | 35 | X | X |
WB = Western Blot, IF- Immunofluorescence, IP- Chromatin immunoprecipitation.